Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

17.52

+0.22 (1.27%)

At close: May 12, 2025, 4:00 PM

17.52

0.00 (0.00%)

After-hours: May 12, 2025, 4:39 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $2.20 billion as of May 12, 2025. Its market cap has decreased by -63.43% in one year.

Market Cap

2.20B

Enterprise Value

2.31B

1-Year Change

-63.43%

Ranking

#1824

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.20B, an increase of 218.63%. That is a compound annual growth rate of 16.71%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	2.17B	-45.22%
Dec 31, 2024	3.97B	-44.04%
Dec 29, 2023	7.09B	24.06%
Dec 30, 2022	5.72B	24.22%
Dec 31, 2021	4.60B	6.25%
Dec 31, 2020	4.33B	121.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	677.20B
Johnson & Johnson	371.45B
UnitedHealth Group	344.06B
AbbVie	337.39B
Novo Nordisk	292.03B
Abbott Laboratories	229.62B
Novartis AG	213.30B
AstraZeneca	210.42B

Market Cap Rankings